| Literature DB >> 32894010 |
K Omiya1, K Hiramatsu1, T Kato1, Y Shibata1, M Yoshihara1, T Aoba1, A Arimoto1, A Ito1.
Abstract
BACKGROUND: Severe inflammation with necrosis and fibrosis of the gallbladder in acute cholecystitis increases operative difficulty during laparoscopic cholecystectomy. This study aimed to assess the use of preoperative MRI in predicting pathological changes of the gallbladder associated with surgical difficulty.Entities:
Year: 2020 PMID: 32894010 PMCID: PMC7709376 DOI: 10.1002/bjs5.50344
Source DB: PubMed Journal: BJS Open ISSN: 2474-9842
Fig. 1Layered pattern of the gallbladder wall
Fig. 2Flow diagram of patient selection
Characteristics of the three groups
| HSI group ( | ISI group ( | LSI group ( |
| |
|---|---|---|---|---|
|
| ||||
| Age (years) | 59 (46–68) | 65 (51–73) | 67 (57–75) | 0·068 |
| Sex ratio (M : F) | 36 : 26 | 67 : 32 | 45 : 23 | 0·439 |
| BMI (kg/m2) | 25·0 (21·3–28·1) | 24·3 (21·8–27·4) | 24·8 (22·4–27·1) | 0·878 |
| ASA physical status | 0·037 | |||
| I | 28 (45) | 34 (34) | 21 (31) | |
| II | 34 (55) | 59 (60) | 39 (57) | |
| III | 0 (0) | 6 (6) | 8 (12) | |
| Diabetes mellitus | 11 (18) | 14 (14) | 15 (22) | 0·418 |
| Previous diagnosis of gallstones | 17 (27) | 34 (34) | 22 (32) | 0·793 |
| Past gallbladder attack | 13 (21) | 17 (17) | 14 (21) | 0·790 |
| Past acute cholecystitis | 3 (5) | 7 (7) | 7 (10) | 0·530 |
|
| ||||
| Body temperature (°C) | 36·7 (36·3–37·2) | 37·0 (36·6–37·5) | 37·0 (36·6–37·6) | 0·029 |
| Preoperative gallbladder drainage | 0 (0) | 2 (2) | 1 (1) | 0·789 |
| Thickness of gallbladder wall on MRI (mm) | 5 (4–7) | 7 (6–8) | 7 (6–9) | < 0·001 |
| Gallstones recognized on MRI | 53 (85) | 83 (84) | 53 (78) | 0·117 |
| WBC (cells/μl) | 10 135 (8445–13 960) | 10 670 (8835–14 615) | 12 715 (9470–15 512) | 0·054 |
| CRP (mg/dl) | 0·31 (0·08–1·05) | 0·60 (0·14–5·99) | 6·51 (1·18–15·14) | < 0·001 |
| AST (units/l) | 24 (19–37) | 24 (18–33) | 24 (19–34) | 0·721 |
| ALT (units/l) | 26 (18–39) | 23 (17–41) | 25 (16–52) | 0·519 |
| ALP (units/l) | 213 (163–283) | 223 (184–289) | 221 (183–282) | 0·442 |
| Total bilirubin (mg/dl) | 0·7 (0·5–1·0) | 1·0 (0·7–1·6) | 1·0 (0·7–1·5) | < 0·001 |
| Severity grade | 0·037 | |||
| I | 60 (97) | 86 (87) | 57 (84) | |
| II | 2 (3) | 13 (13) | 11 (16) | |
|
| ||||
| Type of surgery | < 0·001 | |||
| Laparoscopic | 60 (97) | 81 (82) | 42 (62) | |
| Open conversion | 0 (0) | 8 (8) | 14 (21) | |
| Open | 2 (3) | 10 (10) | 12 (18) | |
| Time from disease onset to surgery (h) | 0·114 | |||
| ≤ 48 | 55 (89) | 78 (79) | 51 (75) | |
| > 48 | 7 (11) | 21 (21) | 17 (25) |
Values in parentheses are percentages unless indicated otherwise;
values are median (range).
Assessed according to Tokyo Guidelines of 2007, 2013 and 2018. HSI, high signal intensity; ISI, intermediate signal intensity; LSI, low signal intensity; WBC, white blood cell; CRP, C‐reactive protein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase.
Fisher's exact test, except
Kruskal–Wallis test.
Pathological outcomes in the three groups
| HSI group ( | ISI group ( | LSI group ( |
| |
|---|---|---|---|---|
|
| 17 (27) | 84 (85) | 66 (97) | < 0·001 |
|
| ||||
| Necrosis | 9 (15) | 51 (52) | 49 (72) | < 0·001 |
| Abscess formation | 2 (3) | 8 (8) | 9 (13) | 0·126 |
| Fibrosis | 10 (16) | 50 (51) | 37 (54) | < 0·001 |
Values in parentheses are percentages. HSI, high signal intensity; ISI, intermediate signal intensity; LSI, low signal intensity.
Fisher's exact test.
In pairwise comparisons: P < 0·001 (HSI versus ISI), P = 0·010 (ISI versus LSI) and P < 0·001 (LSI versus HSI);
in pairwise comparisons: P < 0·001 (HSI versus ISI), P = 0·640 (ISI versus LSI) and P < 0·001 (LSI versus HSI) (Fisher's exact test with adjustment by Holm method).
Characteristics of the subgroups of patients undergoing surgery within 48 h of disease onset
| HSI group ( | ISI group ( | LSI group ( |
| |
|---|---|---|---|---|
|
| ||||
| Age (years) | 60 (49–69) | 65 (51–71) | 67 (59–75) | 0·129 |
| Sex ratio (M : F) | 32 : 23 | 53 : 25 | 31 : 20 | 0·439 |
| BMI (kg/m2) | 25·0 (21·3–28·1) | 24·3 (21·8–27·4) | 24·8 (22·4–27·1) | 0·484 |
| ASA physical status | 0·026 | |||
| I | 26 (47) | 26 (33) | 17 (33) | |
| II | 29 (53) | 48 (62) | 27 (53) | |
| III | 0 (0) | 4 (5) | 7 (14) | |
| Diabetes mellitus | 10 (18) | 11 (14) | 13 (25) | 0·262 |
| Previous diagnosis of gallstones | 14 (25) | 27 (35) | 18 (35) | 0·471 |
| Past gallbladder attack | 11 (20) | 14 (18) | 11 (22) | 0·891 |
| Past acute cholecystitis | 2 (4) | 4 (5) | 6 (12) | 0·244 |
|
| ||||
| Body temperature (°C) | 36·6 (36·2–37·2) | 36·9 (36·3–37·5) | 36·9 (36·5–37·7) | 0·038 |
| Preoperative gallbladder drainage | 0 (0) | 1 (1·3) | 0 (0) | 1·000 |
| Thickness of gallbladder wall on MRI (mm) | 5 (4–7) | 7 (6–8) | 7 (6–9) | < 0·001 |
| Gallstones recognized on MRI | 47 (85) | 67 (86) | 42 (82) | 0·869 |
| WBC (cells/μl) | 11 260 (8850–14 140) | 10 595 (8873–14 060) | 12 690 (9440–15 835) | 0·141 |
| CRP (mg/dl) | 0·25 (0·08–0·85) | 0·52 (0·12–5·12) | 3·18 (0·47–11·39) | < 0·001 |
| AST (units/l) | 24 (19–34) | 25 (18–33) | 25 (19–42) | 0·972 |
| ALT (units/l) | 25 (18–38) | 23 (17–43) | 25 (16–54) | 0·919 |
| ALP (units/l) | 206 (161–272) | 222 (182–288) | 217 (174–285) | 0·240 |
| Total bilirubin (mg/dl) | 0·6 (0·2–0·9) | 1·0 (0·7–1·6) | 1·0 (0·7–1·5) | < 0·001 |
| Severity grade | 0·049 | |||
| I | 53 (96) | 68 (87) | 42 (82) | |
| II | 2 (4) | 10 (13) | 9 (18) | |
|
| < 0·001 | |||
| Laparoscopic | 55 (100) | 66 (85) | 33 (65) | |
| Open conversion | 0 (0) | 6 (8) | 11 (22) | |
| Open | 0 (0) | 6 (8) | 7 (14) |
Values in parentheses are percentages unless indicated otherwise;
values are median (range).
Assessed according to Tokyo Guidelines of 2007, 2013 and 2018. HSI, high signal intensity; ISI, intermediate signal intensity; LSI, low signal intensity; WBC, white blood cell; CRP, C‐reactive protein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase.
Fisher's exact test, except
Kruskal–Wallis test.
Pathological outcomes in the subgroup of patients undergoing surgery within 48 h of disease onset
| HSI group ( | ISI group ( | LSI group ( |
| |
|---|---|---|---|---|
|
| 14 (25) | 66 (85) | 50 (98) | < 0·001 |
|
| ||||
| Necrosis | 8 (15) | 36 (46) | 37 (73) | < 0·001 |
| Abscess formation | 2 (4) | 5 (6) | 7 (14) | 0·149 |
| Fibrosis | 7 (13) | 40 (51) | 26 (51) | < 0·001 |
Values in parentheses are percentages. HSI, high signal intensity; ISI, intermediate signal intensity; LSI, low signal intensity.
Fisher's exact test.
In pairwise comparisons: P < 0·001 (HSI versus ISI), P = 0·015 (ISI versus LSI) and P < 0·001 (LSI versus HSI);
in pairwise comparisons: P < 0·001 (HSI versus ISI), P = 0·004 (ISI versus LSI) and P < 0·001 (LSI versus HSI);
in pairwise comparison: P < 0·001 (HSI versus ISI), P = 1·000 (ISI versus LSI) and P < 0·001 (LSI versus HSI) (Fisher's exact test with adjustment by Holm method).